Profiles of patients with psoriasis for appointment gene-engineering biological therapy — clinical justification
| Autor: | Alkes A. Khotko, Aleksey V. Samtsov, V. R. Khairutdinov, Alexander S. Zhukov |
|---|---|
| Jazyk: | ruština |
| Rok vydání: | 2020 |
| Předmět: |
profiles
medicine.medical_specialty Disease Dermatology Lesion Psoriatic arthritis Therapeutic approach onychodystrophy Psoriasis medicine Sex organ personalised therapy psoriatic arthritis therapy integumentary system business.industry psoriasis medicine.disease Regimen Infectious Diseases medicine.anatomical_structure Scalp RL1-803 medicine.symptom business netakimab problematic localization of eruptions |
| Zdroj: | Vestnik Dermatologii i Venerologii, Vol 96, Iss 1, Pp 58-66 (2020) |
| ISSN: | 2313-6294 0042-4609 |
| Popis: | Psoriasis is a chronic immune-mediated disease with predominant damage to the skin and musculoskeletal system. This paper describes the clinical manifestations of psoriasis requiring a special therapeutic approach. The profiles of patients who showed the early assignment of genetic engineering biological therapy: patients with moderate and severe psoriasis, with rashes of problem localization (skin of the face, scalp, genital area and palmar-plantar region), with severe psoriatic lesion of the nail plates, as well as psoriatic arthritis. Clinical cases of rapid and pronounced resolution of rashes with the use of the new drug netakimab (Efleira) in a dosage of 120 mg according to the standard regimen psoriasis patients with indications for systemic or phototherapy. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|